Oncology Institute (DFPH) Preferred Stock Liabilities (2020 - 2021)
Oncology Institute posted quarterly Preferred Stock Liabilities of $230.0 million for Q3 2021, up 767.68% year-on-year from $26.5 million in Q3 2020, and up 680.44% on a QoQ basis from $29.5 million in Q2 2021.
Oncology Institute (DFPH) has 2 years of Preferred Stock Liabilities data on file, last reported at $230.0 million in Q3 2021.
- For the quarter ending Q3 2021, Preferred Stock Liabilities rose 767.68% year-over-year to $230.0 million; the trailing twelve-month figure through Sep 2021 stood at $230.0 million (up 767.68% YoY), and the FY2020 full-year result was $230.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q3 2021 stood at $230.0 million, up from $29.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $230.0 million in Q1 2020 and bottomed at $23.3 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | - |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | - |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | - |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | Oncology Institute | - | - | 139.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 230.00 Mn |
| Jun 30, 2021 | 29.47 Mn |
| Mar 31, 2021 | 23.35 Mn |
| Dec 31, 2020 | 230.00 Mn |
| Sep 30, 2020 | 26.51 Mn |
| Jun 30, 2020 | 205.91 Mn |
| Mar 13, 2020 | 230.00 Mn |